ANVS Competitors & Alternatives
Compare Annovis Bio Inc with similar stocks in the same industry
Biotechnology
ANVS
Main Stock$1.97
Tradestie Score
58
Market Cap
$41.51M
Analyst Upside
+534.5%
Top Competitors
238 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$19.63
|
$154.27M | - | 56 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$13.27
|
$133.50M | - | 63 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$7.24
|
$114.01M | - | 55 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$26.22
|
$110.20M | - | 59 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.61
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.63
|
$76.55M | - | 61 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.33
|
$71.69M | - | 56 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.45
|
$67.94M | - | 57 | Compare |
|
INMB
INmune Bio Inc. Common stock
|
$1.67
|
$56.63M | - | 49 | Compare |
|
LGVN
Longeveron Inc. Common Stock
|
$0.65
|
$15.64M | - | 52 | Compare |
More ANVS Analysis
Data updated: Jul 06, 2026 | Industry: Biotechnology (SIC 2834)
238 stocks in this industry